SB-505124

CAS No. 694433-59-5

SB-505124( SB505124 | SB-505124 | SB 505124 )

Catalog No. M15656 CAS No. 694433-59-5

SB505124 is a selective inhibitor of TGFβR for ALK4, ALK5 with IC50 of 129 nM and 47 nM in cell-free assays, respectively, also inhibits ALK7, but does not inhibit ALK1, 2, 3, or 6.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 135 In Stock
2MG 46 In Stock
5MG 77 In Stock
10MG 123 In Stock
25MG 221 In Stock
50MG 365 In Stock
100MG 536 In Stock
200MG Get Quote In Stock
500MG 1135 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SB-505124
  • Note
    Research use only, not for human use.
  • Brief Description
    SB505124 is a selective inhibitor of TGFβR for ALK4, ALK5 with IC50 of 129 nM and 47 nM in cell-free assays, respectively, also inhibits ALK7, but does not inhibit ALK1, 2, 3, or 6.
  • Description
    SB505124 is a selective inhibitor of TGFβR for ALK4, ALK5 with IC50 of 129 nM and 47 nM in cell-free assays, respectively, also inhibits ALK7, but does not inhibit ALK1, 2, 3, or 6.
  • In Vitro
    SB-505124 demonstrates no toxicity to renal epithelial A498 cells at concentrations up to 100 μM for 48 h. 505124 inhibits the closely related ALK4 with an IC50 value of 129±11 nM (about 2.5-fold less sensitive than ALK5) but does not inhibit ALK2 at concentrations up to 10 μM. SB-505124 (1 μM) inhibits the TGF-β-induced phosphorylation of Smad2 in all three of these cell lines in a concentration-dependent fashion. SB-505124 (1 or 5 μM) potently inhibits TGF-β-induced activation of JNK/SAP, extracellular signal-regulated kinase 1/2, and p38 despite the different patterns of activation in these cells. SB-505124 (10 μM) impairs Smad2 phosphorylation and CTGF and α-SMA expression in vitro. SB-505124 susspresses CTGF and α-SMA observed by immunofluorescence. Cell outgrowth from explants dissected from eyes to which SB-505124 is applied during GFS is robust while outgrowth is poor from those treated with MMC.
  • In Vivo
    SB-505124 (5 mg/kg; i.p.) alone has no effect in C57Bl6 mice with A549 xenografts, but administration of SB-505124 with a single dose of Carboplatin (60 mg/kg) results in durable responses without the need for maintenance therapy in five animals. Animal Model:C57Bl6 mice with A549 xenografts Dosage:5 mg/kg Administration:I.p.; daily Result:Had no effect alone, but administration with a single dose of carboplatin (60 mg/kg) resulted in durable responses without the need for maintenance therapy in five animals.
  • Synonyms
    SB505124 | SB-505124 | SB 505124
  • Pathway
    Angiogenesis
  • Target
    ALK
  • Recptor
    ALK4| ALK5
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    694433-59-5
  • Formula Weight
    335.4
  • Molecular Formula
    C20H21N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 67 mg/mL (199.76 mM); DMSO: 67 mg/mL (199.76 mM)
  • SMILES
    CC1=CC=CC(C2=C(C3=CC=C(OCO4)C4=C3)N=C(C(C)(C)C)N2)=N1
  • Chemical Name
    2-(4-(benzo[d][1,3]dioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl)-6-methylpyridine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. DaCosta Byfield S, et al. Mol Pharmacol. 2004, 65(3), 744-752.
molnova catalog
related products
  • Iruplinalkib

    Iruplinalkib (WX-0593) is an orally active, selective and potent ALK and ROS1 tyrosine kinase inhibitor with anticancer activity for use in the study of non-small cell lung cancer.

  • AP26113

    AP26113 is a potent ALK inhibitor with IC50 of 0.62 nM in a cell-free assay.

  • CEP-28122

    A highly potent and selective, orally active ALK inhibitor with IC50 of 1.9 nM.